• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与起搏器共同生活:起搏器系统的患者报告结局

Living with a pacemaker: patient-reported outcome of a pacemaker system.

作者信息

Magnusson Peter, Liv Per

机构信息

Cardiology Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital/Solna, SE-171 76, Stockholm, Sweden.

Centre for Research and Development, Uppsala University/Region Gävleborg, Gävle, Sweden.

出版信息

BMC Cardiovasc Disord. 2018 Jun 4;18(1):110. doi: 10.1186/s12872-018-0849-6.

DOI:10.1186/s12872-018-0849-6
PMID:29866050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5987385/
Abstract

BACKGROUND

The aim of this study was to assess among pacemaker patients their overall satisfaction with the pacemaker system, pain, soreness/discomfort, cosmetic results, restrictions due to impaired movement of the shoulder/arm/chest, related sleep disturbances, and concern about possible device malfunction.

METHODS

The seven-item questionnaire was mailed to patients from a single center who had a pacemaker implant or replacement between 2006 and 2016. A higher score indicated worse outcome on a visual analog scale (VAS) of 0-100 mm.

RESULTS

The response rate was 75.5% and 342 questionniares were analyzed. Median age of respondents was 77.6 years and 57.0% were males. In total, 65 complications requiring surgery (10 pocket corrections (2.9%), 5 in females) occurred during a median follow-up of 5.6 years.The distribution of the primary outcome had a median score of 5 while the 75th percentile was 13. Cosmetic appearance was significantly associated with reoperation (but not other variables). Overall scores for men and women were 5 vs. 6, respectively, which achieved significance (p = 0.042). Median ratings of pain, soreness/discomfort, cosmetic appearance, range of motion, sleep, and concern about device malfunction were all ≤5. Females reported worse outcomes for all questions, except for cosmetic results and concern about malfunction.

CONCLUSIONS

The vast majority of patients report excellent overall satisfaction with the pacemaker system, and are not affected by pain, soreness/discomfort, or concern about device malfunction. They also reported favourable outcomes with respect to cosmetic results, shoulder movement, and sleep. However, some patients underwent a surgical correction of the pacemaker pocket.

摘要

背景

本研究旨在评估起搏器患者对起搏器系统的总体满意度、疼痛、酸痛/不适、外观效果、因肩部/手臂/胸部活动受限导致的限制、相关睡眠障碍以及对设备可能出现故障的担忧。

方法

向来自单一中心的2006年至2016年间植入或更换起搏器的患者邮寄了一份包含七个项目的问卷。较高的分数表明在0至100毫米的视觉模拟量表(VAS)上结果更差。

结果

回复率为75.5%,共分析了342份问卷。受访者的中位年龄为77.6岁,男性占57.0%。在中位随访5.6年期间,共发生65例需要手术的并发症(10例囊袋矫正(2.9%),其中女性5例)。主要结局的分布中位数为5分,第75百分位数为13分。外观与再次手术显著相关(但与其他变量无关)。男性和女性的总体得分分别为5分和6分,具有显著性差异(p = 0.042)。疼痛、酸痛/不适、外观、活动范围、睡眠以及对设备故障的担忧的中位评分均≤5分。除外观效果和对故障的担忧外,女性在所有问题上报告的结果更差。

结论

绝大多数患者对起搏器系统总体满意度极高,且不受疼痛、酸痛/不适或对设备故障的担忧影响。他们在外观效果、肩部活动和睡眠方面也报告了良好的结果。然而,一些患者接受了起搏器囊袋的手术矫正。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dc8/5987385/18a8967751dc/12872_2018_849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dc8/5987385/db09712bcca7/12872_2018_849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dc8/5987385/18a8967751dc/12872_2018_849_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dc8/5987385/db09712bcca7/12872_2018_849_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dc8/5987385/18a8967751dc/12872_2018_849_Fig2_HTML.jpg

相似文献

1
Living with a pacemaker: patient-reported outcome of a pacemaker system.与起搏器共同生活:起搏器系统的患者报告结局
BMC Cardiovasc Disord. 2018 Jun 4;18(1):110. doi: 10.1186/s12872-018-0849-6.
2
Quality of life of patients undergoing conventional vs leadless pacemaker implantation: A multicenter observational study.传统起搏器与无导线起搏器植入患者的生活质量:一项多中心观察性研究。
J Cardiovasc Electrophysiol. 2020 Jan;31(1):330-336. doi: 10.1111/jce.14322. Epub 2019 Dec 19.
3
Twenty-Seven Years Experience With Transvenous Pacemaker Implantation in Children Weighing <10 kg.对体重小于10公斤儿童进行经静脉起搏器植入的27年经验
Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e003422. doi: 10.1161/CIRCEP.115.003422.
4
Leadless pacemaker: Performance and complications.无导线起搏器:性能与并发症。
Trends Cardiovasc Med. 2018 Feb;28(2):130-141. doi: 10.1016/j.tcm.2017.08.001. Epub 2017 Aug 9.
5
Rehospitalizations for complications and mortality following pacemaker implantation: A retrospective cohort study in an older population.起搏器植入术后并发症再入院情况及死亡率:一项老年人群的回顾性队列研究。
Clin Cardiol. 2018 Nov;41(11):1480-1486. doi: 10.1002/clc.23091. Epub 2018 Oct 19.
6
The managed ventricular pacing algorithm can be misinterpreted as pacemaker malfunction.心室起搏管理算法可能会被误解为起搏器故障。
Europace. 2013 Dec;15(12):1783. doi: 10.1093/europace/eut091. Epub 2013 Apr 16.
7
Leadless pacemaker versus transvenous single-chamber pacemaker therapy: A propensity score-matched analysis.无导线起搏器与经静脉单腔起搏器治疗:倾向评分匹配分析。
Heart Rhythm. 2018 Sep;15(9):1387-1393. doi: 10.1016/j.hrthm.2018.04.027. Epub 2018 Apr 28.
8
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study.经导管起搏系统的长期性能:来自Micra经导管起搏研究的12个月结果。
Heart Rhythm. 2017 May;14(5):702-709. doi: 10.1016/j.hrthm.2017.01.035. Epub 2017 Feb 10.
9
The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker.Micra经导管起搏研究的基本原理与设计:新型小型化起搏器的安全性与有效性
Europace. 2015 May;17(5):807-13. doi: 10.1093/europace/euv026. Epub 2015 Apr 7.
10
Pacemaker Troubleshooting: Common Clinical Scenarios.起搏器故障排查:常见临床情况
Tex Heart Inst J. 2016 Oct 1;43(5):415-418. doi: 10.14503/THIJ-16-5918. eCollection 2016 Oct.

引用本文的文献

1
Efficacy of Shoulder Rehabilitation Post-Cardiac Implantable Electronic Device Implantation.心脏植入式电子设备植入术后肩部康复的疗效
J Clin Med. 2024 Nov 21;13(23):7014. doi: 10.3390/jcm13237014.
2
Cost-effectiveness of Micra™ VR leadless pacemaker in patients with bradycardia and atrial fibrillation in Australia.Micra™ VR无导线起搏器在澳大利亚心动过缓和心房颤动患者中的成本效益
J Arrhythm. 2024 Sep 27;40(6):1481-1489. doi: 10.1002/joa3.13145. eCollection 2024 Dec.
3
Postoperative intravenous patient-controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation.

本文引用的文献

1
Placement Of Cardiac PacemaKEr Trial (POCKET) - rationale and design: a randomized controlled trial.心脏起搏器植入试验(POCKET)——原理与设计:一项随机对照试验
Heart Int. 2017 Apr 14;12(1):e8-e11. doi: 10.5301/heartint.5000235. eCollection 2017 Jan-Dec.
2
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study.经导管起搏系统的长期性能:来自Micra经导管起搏研究的12个月结果。
Heart Rhythm. 2017 May;14(5):702-709. doi: 10.1016/j.hrthm.2017.01.035. Epub 2017 Feb 10.
3
A Leadless Intracardiac Transcatheter Pacing System.
术后静脉自控镇痛可改善皮下植入式心脏除颤器植入术后的疼痛管理。
J Arrhythm. 2024 Feb 28;40(2):349-355. doi: 10.1002/joa3.13006. eCollection 2024 Apr.
4
Passive and Flexible Wireless Electronics Fabricated on Parylene/PDMS Substrate for Stimulation of Human Stem Cell-Derived Cardiomyocytes.基于对二甲苯/聚二甲基硅氧烷基底的被动式和灵活式无线电子器件的构建及其对人诱导多能干细胞衍生心肌细胞的刺激作用
ACS Sens. 2022 Nov 25;7(11):3287-3297. doi: 10.1021/acssensors.2c00794. Epub 2022 Oct 25.
5
Wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal models.用于小动物模型应用的无线、无电池、完全可植入的多模态和多部位起搏器。
Nat Commun. 2019 Dec 17;10(1):5742. doi: 10.1038/s41467-019-13637-w.
6
Assessment of fatigue in patients with a permanent cardiac pacemaker: prevalence and associated factors.永久性心脏起搏器患者疲劳状况的评估:患病率及相关因素
Arch Med Sci Atheroscler Dis. 2018 Dec 20;3:e166-e173. doi: 10.5114/amsad.2018.81085. eCollection 2018.
无导线心脏内介入起搏系统。
N Engl J Med. 2016 Feb 11;374(6):533-41. doi: 10.1056/NEJMoa1511643. Epub 2015 Nov 9.
4
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状:来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
5
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.心脏植入式电子设备植入后的并发症:丹麦全国完整队列分析
Eur Heart J. 2014 May;35(18):1186-94. doi: 10.1093/eurheartj/eht511. Epub 2013 Dec 17.
6
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).2013年欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗指南:欧洲心脏病学会(ESC)心脏起搏与心脏再同步治疗特别工作组。与欧洲心律协会(EHRA)合作制定。
Europace. 2013 Aug;15(8):1070-118. doi: 10.1093/europace/eut206. Epub 2013 Jun 24.
7
Long term quality-of-life in patients with bradycardia pacemaker implantation.植入缓慢性心律失常起搏器患者的长期生活质量
Int J Cardiol. 2013 Oct 3;168(3):2159-63. doi: 10.1016/j.ijcard.2013.01.253. Epub 2013 Feb 28.
8
Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study.起搏器治疗的短期和长期并发症的发生率和预测因素:FOLLOWPACE 研究。
Heart Rhythm. 2012 May;9(5):728-35. doi: 10.1016/j.hrthm.2011.12.014. Epub 2011 Dec 17.
9
Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients.心脏起搏中铅并发症的风险因素:一项基于人群的 28860 名丹麦患者的队列研究。
Heart Rhythm. 2011 Oct;8(10):1622-8. doi: 10.1016/j.hrthm.2011.04.014. Epub 2011 Apr 14.
10
Pacemaker and defibrillator lead extraction.起搏器和除颤器导线拔除术。
Circulation. 2011 Mar 22;123(11):e378-80. doi: 10.1161/CIRCULATIONAHA.110.987354.